Prevention of COPD exacerbations:: how to conduct a clinical trial evaluating the benefits of inhaled steroids?

被引：2

作者：

Chabot, F

Devillier, P

Drugeon, H

Dusser, D

Fournier, M

Gaillat, J

Grouin, JM

Housset, B

Huchon, G

Léophonte, P

Muir, JF

Raffy, O

Tonnel, AB

Tremolieres, F

Zück, P

Attali, V

Boucot, I

Chemali-Hudry, J

Daniloski, M

机构：

[1] CHU Nancy Brabois, Serv Maladies Resp & Reanimat Resp, Vandoeuvre Les Nancy, France

[2] CHU Reims, Hop Maison Blanche, Serv Pharmacol, Reims, France

[3] Hop Hotel Dieu, Nantes, France

[4] Hop Cochin, Serv Pneumol, F-75674 Paris, France

[5] Hop Beaujon, Serv Pneumol, Clichy, France

[6] Hop Annecy, Serv Malad Infect, Annecy, France

[7] Ctr Hosp Intercommunal, Serv Pneumol, Creteil, France

[8] Hop Hotel Dieu, Serv Pneumol & Reanimat, Paris, France

[9] Hop Larrey, Serv Pneumol, Toulouse, France

[10] CHU Rouen, Serv Pneumol, Unite Soins Intens Resp, Rouen, France

[11] Hop Louis Pasteur, Ctr Hosp Gen Chartres, Serv Pneumol, Chartres, France

[12] CHRU Lille, Hop Calmette, Serv Pneumol & Immuno Allergol, Lille, France

[13] CH Mantes La Jolie, Serv Pneumol, Mantes La Jolie, France

[14] CH Bon Secours, Serv Pneumol, Metz, France

[15] Labs GSK, Marly Le Roy, France

来源：

REVUE DES MALADIES RESPIRATOIRES | 2004年 / 21卷 / 04期

关键词：

D O I：

10.1016/S0761-8425(04)71408-4

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页码：685 / 688

页数：4

共 16 条

[1] The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: A systematic review of randomized placebo-controlled trials
Alsaeedi, A
Sin, DD
McAlister, FA
[J]. AMERICAN JOURNAL OF MEDICINE, 2002, 113 (01) : 59 - 65
[2] Altose MD, 2000, NEW ENGL J MED, V343, P1902
[3] ANTIBIOTIC-THERAPY IN EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
ANTHONISEN, NR
MANFREDA, J
WARREN, CPW
HERSHFIELD, ES
HARDING, GKM
NELSON, NA
[J]. ANNALS OF INTERNAL MEDICINE, 1987, 106 (02) : 196 - 204
[4] Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial
Burge, PS
Calverley, PMA
Jones, PW
Spencer, S
Anderson, JA
Maslen, TK
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2000, 320 (7245): : 1297 - 1303
[5] Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease
Donaldson, GC
Seemungal, TAR
Bhowmik, A
Wedzicha, JA
[J]. THORAX, 2002, 57 (10) : 847 - 852
[6] FOURNIER M, 2003, IMPACT SOCIO EC BPCO
[7] An observational study of inhaled corticosteroid withdrawal in stable chronic obstructive pulmonary disease
Jarad, NA
Wedzicha, JA
Burge, PS
Calverley, PMA
[J]. RESPIRATORY MEDICINE, 1999, 93 (03) : 161 - 166
[8] Lower respiratory illnesses promote FEV1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease -: Results from the Lung Health Study
Kanner, RE
Anthonisen, NR
Connett, JE
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (03) : 358 - 364
[9] Costs of chronic bronchitis and COPD - A 1-year follow-up study
Miravitlles, M
Murio, C
Guerrero, T
Gisbert, R
[J]. CHEST, 2003, 123 (03) : 784 - 791
[10] Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease
Paggiaro, PL
Dahle, R
Bakran, I
Frith, L
Hollingworth, K
Efthimiou, J
[J]. LANCET, 1998, 351 (9105) : 773 - 780

← 1 2 →